Drugs / MK-8655
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01640873 | Sep → Dec 2012 | type 2 diabetes mellitus | Merck Sharp & Dohme LLC | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-8655 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01640873 ↗ |
| Route | Oral | “single and multiple daily oral administrations” NCT01640873 ↗ |